Vanda Pharmaceuticals (VNDA) Prepaid Assets (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Prepaid Assets of $32.3 million for Q1 2026, up 57.65% on a YoY basis from $20.5 million in Q1 2025, and up 19.63% sequentially from $27.0 million in Q4 2025.
Vanda Pharmaceuticals (VNDA) Prepaid Assets (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of Prepaid Assets data on file, last reported at $32.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 57.65% year-over-year to $32.3 million; the trailing twelve-month figure through Mar 2026 stood at $32.3 million (up 57.65% YoY), and the FY2025 full-year result was $27.0 million, up 75.0% from the prior year.
- Prepaid Assets advanced to $32.3 million in Q1 2026, from $27.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $32.3 million in Q1 2026 to a low of $6.6 million in Q1 2023.
- A 5-year average of $17.5 million and a median of $17.7 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets tumbled 73.95% in 2023 and surged 189.82% in 2025, its largest moves.
- Tracing VNDA's Prepaid Assets over 5 years: stood at $17.7 million in 2022, then tumbled by 48.27% to $9.2 million in 2023, then soared by 68.16% to $15.4 million in 2024, then jumped by 75.0% to $27.0 million in 2025, then advanced by 19.63% to $32.3 million in 2026.
- Business Quant data shows VNDA's Prepaid Assets at $32.3 million in Q1 2026, $27.0 million in Q4 2025, and $21.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.28 Mn |
| Dec 31, 2025 | 26.99 Mn |
| Sep 30, 2025 | 21.16 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Dec 31, 2024 | 15.42 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 8.17 Mn |
| Mar 31, 2024 | 7.07 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Sep 30, 2023 | 16.44 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 6.59 Mn |
| Dec 31, 2022 | 17.73 Mn |
| Sep 30, 2022 | 21.37 Mn |
| Jun 30, 2022 | 25.74 Mn |
| Mar 31, 2022 | 25.31 Mn |
| Dec 31, 2021 | 12.00 Mn |
| Sep 30, 2021 | 13.44 Mn |
| Jun 30, 2021 | 12.01 Mn |